AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

ALGN · NASDAQ · Medical - Devices

Align Technology (ALGN)

Builds Invisalign aligners, iTero scanners, and exocad software for digital dentistry.

$153.29

After hours−0.10 (−0.07%)

At close$153.39(+4.43%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	960	957	997	1,028	978	995	979	1,012	996	1,048	1,040	1,056
Cost of revenue	297	287	300	306	296	298	299	304	356	359	304	368
Gross profit	663	670	698	723	682	697	680	708	639	688	737	688
	497	498	544	576	519	553	549	545	543	529	564	565
Research & development	89	82	92	92	85	95	97	96	93	83	99	102
Selling, general & administrative	408	403	452	452	434	425	448	449	418	441	465	463
Other expenses	0	13	0	31	0	33	4	0	32	5	0	0
Operating income	166	172	154	147	162	144	131	163	96	160	173	123
	−4	1	4	−3	4	−3	9	10	−2	17	−24	25
Interest income	6	5	4	3	4	9	5	3	3	5	4	5
Interest expense	0	0	0	0	0	0	0	0	2	0	0	0
Other non-operating income	0	−13	−4	−31	0	−33	−4	−10	−60	−17	24	−24
Income before tax	162	173	158	144	166	141	140	174	95	177	149	149
Income tax expense	41	49	53	47	50	37	47	49	38	41	36	40
Net income from continuing operations	121	124	105	97	116	104	93	125	57	136	113	108
Net income	121	124	105	97	116	104	93	125	57	136	113	108
EPS, basic	$1.59	$1.64	$1.40	$1.28	$1.55	$1.39	$1.27	$1.72	$0.78	$1.89	$1.58	$1.51
EPS, diluted	$1.58	$1.64	$1.39	$1.28	$1.55	$1.39	$1.27	$1.72	$0.78	$1.89	$1.57	$1.52
Weighted average shares, basic	77	76	75	75	75	74	74	73	72	72	71	71
Weighted average shares, diluted	77	76	75	75	75	74	74	73	72	72	72	72
EBITDA	203	219	191	214	200	215	174	214	212	279	205	91
Depreciation & amortization	37	34	33	36	38	38	39	41	56	102	57	−57
EBIT	166	185	158	178	162	177	135	174	156	177	149	147